Portside Wealth Group, LLC Dexcom Inc Transaction History

Portside Wealth Group, LLC

  • $726 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$59.83 - $87.57 $22,496 - $32,926
376 Added 8.9%
4,602 $402 Million
Q1 2025

Apr 14, 2025
BUY
$67.74 - $90.75 $5,419 - $7,260
80 Added 1.93%
4,226 $289 Million
Q1 2025

Apr 10, 2025
BUY
$67.74 - $90.75 $283,627 - $379,970
4,187 New
4,187 $326 Million
Q4 2024

Apr 14, 2025
SELL
$65.68 - $81.01 $2,692 - $3,321
-41 Reduced 0.98%
4,146 $322 Million

Others Institutions Holding DXCM

# of Institutions
1,086
Shares Held
376M
Call Options Held
6.76M
Put Options Held
7.24M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Portside Wealth Group, LLC Portfolio

Follow Portside Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portside Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portside Wealth Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email